发明名称 TRANSDERMAL DEVICE FOR THE CONTROLLED ADMINISTRATION OF AT LEAST ONE ACTIVE INGREDIENT TO A PATIENT
摘要 <p>A transdermal device (1) comprising at least one substrate (2) arranged to be applied against the dermal surface or the mucous membrane. The at least one active ingredient is grafted to the substrate (2) by at least one photolabile ligand, and at least one light source (11) operated by a control mechanism arranged to generate light pulses, of a predetermined wavelength, intended to break covalent bonds between the active ingredient and the ligand in order to release the active ingredient from the substrate (2). The substrate (2) comprises at least one porous matrix (6) with a three-dimensional structure comprising a plurality of pits (7) organized in a sponge-like fashion and constructed of a polymer chosen between chitin and chitosan, and the matrix (6) defines at least one three-dimensional tank (8). The active ingredient is contained and grafted by the ligand.</p>
申请公布号 EP2809302(A1) 申请公布日期 2014.12.10
申请号 EP20130712825 申请日期 2013.01.30
申请人 RHENOVIA PHARMA S.A.S. 发明人 FAUPEL, MICHEL;BISCHOFF, SERGE;GEORGE, FLORIAN;STARK, PETER
分类号 A61K9/00;A61K9/70;A61N5/06;A61N5/10 主分类号 A61K9/00
代理机构 代理人
主权项
地址